Gain Therapeutics (GANX)
NASDAQ:GANX
US Market

Gain Therapeutics (GANX) Cash flow

Compare
263 Followers

Gain Therapeutics Cash Flow

GANX's free cash flow for Q3 2024 was $-6.08M. For the 2024 fiscal year, GANX's free cash flow was decreased by $18.86M and operating cash flow was $-6.08M. See a summary of the company’s cash flow.
Cash Flow
Dec 24Dec 23Dec 22Dec 21Dec 20
Operating Cash Flow
$ 0.00$ -18.87M$ -14.69M$ -12.37M$ -3.24M
Investing Cash Flow
$ 4.98M$ 10.22M$ -14.77M$ -94.21K$ -20.83K
Financing Cash Flow
$ 13.01M$ 12.64M$ -78.77K$ 41.77M$ 10.49M
End Cash Position
$ 10.42M$ 11.83M$ 7.34M$ 36.91M$ 7.50M
Free Cash Flow
$ -22.49K$ -18.88M$ -14.81M$ -12.46M$ -3.26M
Currency in USD

Gain Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis